FDA wants data supporting Leronlimab's efficacy. T
Post# of 155138
(Total Views: 721)
Posted On: 04/05/2020 8:26:36 AM
Re: Northstar42 #25497
FDA wants data supporting Leronlimab's efficacy. They already know its safety record. We should have what they want in a couple of weeks plus or minus. IMO they are trying not to let the Leronlimab story get ahead of the science and trial results. Very understandable, but if early trial and lab results (3-5 days) show efficacy, there is an ethical dilemma in not publicly announcing and approving Leronlimab treatment.
_______________
When was it that the powerful of this world were troubled by something silly like "ethical dilemmas"? FDA is married to BP, just as SEC to Wall Street boardrooms, or Pentagon generals to MIC. If the Leronlimab story becomes known to the world, BP and their investors will suffer colossal losses. Leronlimab will explode treatment regiments for dozens if not hundreds of diseases strategic for BP's profits. FDA must keep this story under the lid before BP and their men in power find solution to this problem.
_______________
When was it that the powerful of this world were troubled by something silly like "ethical dilemmas"? FDA is married to BP, just as SEC to Wall Street boardrooms, or Pentagon generals to MIC. If the Leronlimab story becomes known to the world, BP and their investors will suffer colossal losses. Leronlimab will explode treatment regiments for dozens if not hundreds of diseases strategic for BP's profits. FDA must keep this story under the lid before BP and their men in power find solution to this problem.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.